Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Virginia Commonwealth University
Miltenyi Biomedicine GmbH
University of Virginia
OHSU Knight Cancer Institute
Northwestern University
University of Texas Southwestern Medical Center
Masonic Cancer Center, University of Minnesota
Dana-Farber Cancer Institute
University of South Florida
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center